Genzyme talks trigger patient jitters - The Boston Globe: "House suffers from the enzyme defect Pompe disease and takes a Genzyme drug called Myozyme. Treatment with any of the company’s drugs, which also include Cerezyme for Gaucher disease and Fabrazyme for Fabry disease, can cost as much as $300,000 a year.
- Sent using Google Toolbar"
No comments:
Post a Comment